168 related articles for article (PubMed ID: 31916450)
21. Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer.
Vitale SR; Helmijr JA; Gerritsen M; Coban H; van Dessel LF; Beije N; van der Vlugt-Daane M; Vigneri P; Sieuwerts AM; Dits N; van Royen ME; Jenster G; Sleijfer S; Lolkema M; Martens JWM; Jansen MPHM
BMC Cancer; 2021 Mar; 21(1):315. PubMed ID: 33761899
[TBL] [Abstract][Full Text] [Related]
22. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
23. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.
Gezer U; Yörüker EE; Keskin M; Kulle CB; Dharuman Y; Holdenrieder S
Int J Mol Sci; 2015 Dec; 16(12):29654-62. PubMed ID: 26690425
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsies.
Lianidou E; Pantel K
Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
[TBL] [Abstract][Full Text] [Related]
25. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
Ferracin M; Lupini L; Mangolini A; Negrini M
Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
[TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
[No Abstract] [Full Text] [Related]
27. Early detection and monitoring of cancer in liquid biopsy: advances and challenges.
Xue VW; Wong CSC; Cho WCS
Expert Rev Mol Diagn; 2019 Apr; 19(4):273-276. PubMed ID: 30760042
[No Abstract] [Full Text] [Related]
28. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
29. Interplay between regulation by methylation and noncoding RNAs in cancers.
Lu CX; Wu XL; Zhang GY; Gu XT; Ma X; He DX
Eur J Cancer Prev; 2018 Jul; 27(4):418-424. PubMed ID: 29557800
[TBL] [Abstract][Full Text] [Related]
30. Epigenetics of Circulating Tumor Cells in Breast Cancer.
Bao-Caamano A; Rodriguez-Casanova A; Diaz-Lagares A
Adv Exp Med Biol; 2020; 1220():117-134. PubMed ID: 32304083
[TBL] [Abstract][Full Text] [Related]
31. Cell-surface-bound circulating DNA in the blood: Biology and clinical application.
Tamkovich S; Laktionov P
IUBMB Life; 2019 Sep; 71(9):1201-1210. PubMed ID: 31091350
[TBL] [Abstract][Full Text] [Related]
32. Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity.
Gargalionis AN; Papavassiliou AG
Trends Cancer; 2017 Mar; 3(3):166-168. PubMed ID: 28718430
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
Uesato Y; Sasahira N; Ozaka M; Sasaki T; Takatsuki M; Zembutsu H
PLoS One; 2020; 15(7):e0235623. PubMed ID: 32614932
[TBL] [Abstract][Full Text] [Related]
34. The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer.
Alarcón MA; Olivares W; Córdova-Delgado M; Muñoz-Medel M; de Mayo T; Carrasco-Aviño G; Wichmann I; Landeros N; Amigo J; Norero E; Villarroel-Espíndola F; Riquelme A; Garrido M; Owen GI; Corvalán AH
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322837
[TBL] [Abstract][Full Text] [Related]
35. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
36. Liquid Biopsy: General Concepts.
Poulet G; Massias J; Taly V
Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
[TBL] [Abstract][Full Text] [Related]
37. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E
Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients.
Hendriks RJ; Dijkstra S; Smit FP; Vandersmissen J; Van de Voorde H; Mulders PFA; van Oort IM; Van Criekinge W; Schalken JA
Prostate; 2018 Apr; 78(5):336-342. PubMed ID: 29330943
[TBL] [Abstract][Full Text] [Related]
39. Direct detection of early-stage cancers using circulating tumor DNA.
Phallen J; Sausen M; Adleff V; Leal A; Hruban C; White J; Anagnostou V; Fiksel J; Cristiano S; Papp E; Speir S; Reinert T; Orntoft MW; Woodward BD; Murphy D; Parpart-Li S; Riley D; Nesselbush M; Sengamalay N; Georgiadis A; Li QK; Madsen MR; Mortensen FV; Huiskens J; Punt C; van Grieken N; Fijneman R; Meijer G; Husain H; Scharpf RB; Diaz LA; Jones S; Angiuoli S; Ørntoft T; Nielsen HJ; Andersen CL; Velculescu VE
Sci Transl Med; 2017 Aug; 9(403):. PubMed ID: 28814544
[TBL] [Abstract][Full Text] [Related]
40. Opportunities, Challenges, and Prospects in Electrochemical Biosensing of Circulating Tumor DNA and its Specific Features.
Campuzano S; Serafín V; Gamella M; Pedrero M; Yáñez-Sedeño P; Pingarrón JM
Sensors (Basel); 2019 Aug; 19(17):. PubMed ID: 31480367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
